-
Your RFQ cart is empty!
Efinaconazole 13CD2
Chemical Name: (2R,3R)-2-(2,4-difluorophenyl)-3-(4-(methylene-13C-d2)piperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
Smile: C[C@@H](N1CC/C(CC1)=[13C]([2H])/[2H])[C@@](O)(C2=CC=C(F)C=C2F)CN3N=CN=C3
| CAT No: | VS-L102020 |
| CAS No: | NA |
| Mol.F. | C1713CH20D2F2N4O |
| Mol.Wt.: | 351.4 |
| Status: | Custom Synthesis |
Need a Quick Quote for Efinaconazole 13CD2?
Related products
Adenine-2- D1
CAT No: VS-L102000
CAS No: 109923-52-6
Mol.F.: C5H4DN5
Mol.Wt.: 136.13
Status: Custom Synthesis
Adenosine-2 D1
CAT No: VS-L102001
CAS No: 109923-50-4
Mol.F.: C10H12DN5O4
Mol.Wt.: 268.25
Status: Custom Synthesis
Cytidine-5,6 D2
CAT No: VS-L102002
CAS No: 40632-25-5
Mol.F.: C9H11D2N3O5
Mol.Wt.: 245.23
Status: Custom Synthesis
Cytosine-5,6 D2
CAT No: VS-L102003
CAS No: 106391-24-6
Mol.F.: C4H3D2N3O
Mol.Wt.: 113.12
Status: Custom Synthesis
2'-Deoxyuridine-13C,15N2
CAT No: VS-L102004
CAS No: 369656-76-8
Mol.F.: C813CH1215N2O5
Mol.Wt.: 231.18
Status: Custom Synthesis
2'-Deoxyuridine-5,6 D2
CAT No: VS-L102005
CAS No: 40632-23-3
Mol.F.: C9H10D2N2O5
Mol.Wt.: 230.22
Status: Custom Synthesis
5,6-Dihydro Thymine-d6
CAT No: VS-L102006
CAS No: 334473-42-6
Mol.F.: C5H2D6N2O2
Mol.Wt.: 134.17
Status: Custom Synthesis
5,6-Dihydrouracil-5,5,6,6-d4
CAT No: VS-L102007
CAS No: 334473-41-5
Mol.F.: C4H2D4N2O2
Mol.Wt.: 118.13
Status: Custom Synthesis
2′-Fluoro-2'-deoxyuridine-5,6-d2
CAT No: VS-L102008
CAS No: 362049-50-1
Mol.F.: C9H9D2FN2O5
Mol.Wt.: 248.21
Status: Custom Synthesis
5-Methyl-d3-cytosine-6-d1
CAT No: VS-L102009
CAS No: 1219795-15-9
Mol.F.: C5H3D4N3O
Mol.Wt.: 129.16
Status: Custom Synthesis
5-Methyl Uridine-d4
CAT No: VS-L102010
CAS No: 82845-85-0
Mol.F.: C10H10D4N2O6
Mol.Wt.: 262.25
Status: Custom Synthesis
Thymidine-alpha,alpha,alpha,6D4
CAT No: VS-L102011
CAS No: 347841-67-2
Mol.F.: C10H10D4N2O5
Mol.Wt.: 246.26
Status: Custom Synthesis
Thymine-alpha,alpha,alpha,6 D4
CAT No: VS-L102012
CAS No: 156054-85-2
Mol.F.: C5H2D4N2O2
Mol.Wt.: 130.14
Status: Custom Synthesis
Uracil-5-d1
CAT No: VS-L102013
CAS No: 24897-50-5
Mol.F.: C4H3DN2O2
Mol.Wt.: 113.09
Status: Custom Synthesis
Uracil-6-d1
CAT No: VS-L102014
CAS No: 24897-51-6
Mol.F.: C4H3DN2O2
Mol.Wt.: 113.09
Status: Custom Synthesis
Uracil-1,3-d2
CAT No: VS-L102015
CAS No: 20666-60-8
Mol.F.: C4H2D2N2O2
Mol.Wt.: 114.1
Status: Custom Synthesis
Uracil-5,6-d2
CAT No: VS-L102016
CAS No: 24897-52-7
Mol.F.: C4H2D2N2O2
Mol.Wt.: 114.1
Status: Custom Synthesis
Uracil D4
CAT No: VS-L102017
CAS No: 24897-55-0
Mol.F.: C4D4N2O2
Mol.Wt.: 116.11
Status: Custom Synthesis
Uridine-2-13C
CAT No: VS-L102018
CAS No: 35803-42-0
Mol.F.: C813CH12N2O6
Mol.Wt.: 245.2
Status: Custom Synthesis
Uridine-5,6 D2
CAT No: VS-L102019
CAS No: 40632-21-1
Mol.F.: C9H10D2N2O6
Mol.Wt.: 246.22
Status: Custom Synthesis
Efinaconazole 13CD2
CAT No: VS-L102020
CAS No: NA
Mol.F.: C1713CH20D2F2N4O
Mol.Wt.: 351.4
Status: Custom Synthesis
Efinaconazole 13CD6
CAT No: VS-L102021
CAS No: NA
Mol.F.: C1713CH16D6F2N4O
Mol.Wt.: 355.43
Status: Custom Synthesis
Ondansetron 13CD3
CAT No: VS-L102022
CAS No: NA
Mol.F.: C1713CH16D3N3O
Mol.Wt.: 297.38
Status: Custom Synthesis
Hydrochlorothiazide 15N2,13CD2
CAT No: VS-L102023
CAS No: NA
Mol.F.: C613CH6D2ClN15N2O4S2
Mol.Wt.: 302.73
Status: Custom Synthesis
Tacrolimus-13C-D4
CAT No: VS-L102024
CAS No: NA
Mol.F.: C4313CH65D4NO12
Mol.Wt.: 809.04
Status: Custom Synthesis
Riociguat-13C-d3
CAT No: VS-L102025
CAS No: 2749393-44-8
Mol.F.: C1913CH16FN8O2D3
Mol.Wt.: 426.4
Status: Custom Synthesis
Nintedanib-13CD3
CAT No: VS-L102026
CAS No: NA
Mol.F.: C3013CH30D3N5O4
Mol.Wt.: 543.65
Status: Custom Synthesis
5-Methyluridine-1',2',3',4',5'-13C5
CAT No: VS-L102027
CAS No: 159496-17-0
Mol.F.: C513C5H14N2O6
Mol.Wt.: 263.2
Status: Custom Synthesis
rac trans-4-Hydroxy Glyburide-13C,d3
CAT No: VS-L102028
CAS No: 1217639-30-9
Mol.F.: C2213CH25D3ClN3O6S
Mol.Wt.: 514.01
Status: Custom Synthesis
rac cis-3-Hydroxy Glyburide-13C,d3
CAT No: VS-L102029
CAS No: 1217848-91-3
Mol.F.: C2213CH25D3ClN3O6S
Mol.Wt.: 514.01
Status: Custom Synthesis
Contact
040-23076623, 040-4852 9278
E-Mail